Virtual Booth

The emphasis of endodontic treatment has transitioned towards preserving tooth vitality. Nevertheless, a significant challenge in handling endodontic disease is the absence of an objective diagnostic tool, leading to unnecessary treatment of the tooth. This study explores using biomarkers to reflect the pulp status, providing a means to evaluate treatment efficacy. Gingivocrevicular fluid collected from the affected tooth undergoes ELISA testing to measure biomarker concentrations. Incorporating biomarkers in endodontics enhances diagnostic precision, enables early detection, and distinguishes disease severity. It also offers valuable insight into treatment outcomes, supporting precise approaches tailored to the disease stage and promoting effective patient care.